HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, announced today that an overview of the Company’s business strategy will be given at the Rodman & Renshaw Annual Global Investment Conference, being held at the Waldorf-Astoria Hotel in New York City. The Spectrum Pharmaceuticals presentation is at 10:00am Eastern Time on Monday, September 12, 2011, in the Starlight Center room.
